Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
Prosensa Holding NV (NASDAQ: RNA) shares surged 24.37 percent to close at $6.89 a share Thursday. The stock traded between $5.41 and $8.29 on volume 6.38 million shares traded. The company has reported encouraging results from its from the clinical development program of drisapersen for the treatment of Duchenne Muscular Dystrophy. Shares of Prosensa are up approximately 47.0 percent year-to-date.
Get more information on Prosensa and free access to the in-depth equity report at:
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares soared 40.14 percent to close at $28.00 a share Thursday. The stock traded between $22.62 and $28.80 on volume 14.41 million shares traded. The company announced that eteplirsen, its muscle disorder drug, continued the stabilization of walking ability through Week 120. Shares of Sarepta Therapeutics have gained approximately 7.0 percent in the past year.
Get more information on Sarepta Therapeutics and free access to the in-depth equity report at:
Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ) shares jumped 19.87 percent to close at $24.49 a share Thursday. The stock traded between $20.48 and $24.79 on volume of 2.31 million shares traded. Cantor Fitzgerald has recently raised its price target on the company to $27.00 from $20.00. Shares of Zeltiq Aesthetics have gained approximately 390.0 percent in the past year.
Get more information on Zeltiq Aesthetics and free access to the in-depth equity report at:
Zoom Technologies Inc. (NASDAQ: ZOOM) shares spiked 18.37 percent to close at $5.09 a share Thursday. The stock traded between $5.01 and $6.15 on volume 1.39 million shares traded. The company announced that it has acquired Tinho Union Holding Group for $8.6505 per share. Shares of Zoom Technologies have gained approximately 6.0 percent year-to-date.
Get more information on Zoom Technologies free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities